These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11269912)

  • 1. [Electroconvulsive therapy and serotonergic system].
    Ramírez N; Arranz B; Dueñas RM; San L
    Actas Esp Psiquiatr; 2000; 28(5):330-6. PubMed ID: 11269912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the role of pre- and postsynaptic serotonergic receptors in electroconvulsive shock therapy.
    Schoups AA; Beeckman N; Lauwers MC; De Potter WP
    Biol Psychiatry; 1988 Apr; 23(8):807-17. PubMed ID: 3365457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical methodology for studying affective disorders].
    Boullin DJ
    Encephale; 1979; 5(5 Suppl):521-31. PubMed ID: 44862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical prospects in treatment of depressive illness (author's transl)].
    Lôo H; Cuche H
    Ann Biol Clin (Paris); 1979; 37(1):65-72. PubMed ID: 375782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors and the mechanism of action of ECT.
    Lerer B; Belmaker RH
    Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurochemical background of the premenstrual syndrome: the role of the serotonergic system].
    Gonda X; Bagdy G
    Neuropsychopharmacol Hung; 2004 Oct; 6(3):153-62. PubMed ID: 15816306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
    Müller N; Schwarz MJ
    Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical mechanisms of action of ECS: evidence from in vivo studies.
    Newman ME; Gur E; Shapira B; Lerer B
    J ECT; 1998 Sep; 14(3):153-71. PubMed ID: 9773355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unilateral and bilateral shock therapy: mechanism of action (author's transl)].
    Ottosson JO
    Encephale; 1979; 5(5 Suppl):617-25. PubMed ID: 44867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electroconvulsive therapy and its mechanism of action].
    Couvreur V; Ansseau M; Franck G
    Acta Psychiatr Belg; 1989; 89(1-2):96-109. PubMed ID: 2485626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitters and electroconvulsive therapy.
    Baldinger P; Lotan A; Frey R; Kasper S; Lerer B; Lanzenberger R
    J ECT; 2014 Jun; 30(2):116-21. PubMed ID: 24820941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in brain serotonin metabolism and [3H]-serotonin receptor binding during recall of conditioned passive avoidance in rats].
    Molodtsova GF
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(4):533-41. PubMed ID: 15481391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin receptor changes in depression: evidences and limitations].
    Gómez E; Catalán R; Navinés R; Gastó C
    Actas Esp Psiquiatr; 2001; 29(3):186-94. PubMed ID: 11412493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamic changes of brain serotonergic and dopaminergic activities during development of anxious depression: experimental study].
    Avgustinovich DF; Alekseenko OV; Bakshtanovskaia IV; Koriakina LA; Lipina TV; Tenditnik MV; Bondar' NP; Kovalenko IL; Kudriavtseva NN
    Usp Fiziol Nauk; 2004; 35(4):19-40. PubMed ID: 15573884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in 5-HT1B receptor function by p11 in depression-like states.
    Svenningsson P; Chergui K; Rachleff I; Flajolet M; Zhang X; El Yacoubi M; Vaugeois JM; Nomikos GG; Greengard P
    Science; 2006 Jan; 311(5757):77-80. PubMed ID: 16400147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic process in ECT.
    Fink M
    Semin Psychiatry; 1972 Feb; 4(1):39-46. PubMed ID: 4614459
    [No Abstract]   [Full Text] [Related]  

  • 17. Review: Serotonin by stress interaction: a susceptibility factor for the development of depression?
    Firk C; Markus CR
    J Psychopharmacol; 2007 Jul; 21(5):538-44. PubMed ID: 17446201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in zinc homeostasis in depression and antidepressant therapy.
    Nowak G
    Pol J Pharmacol; 1998; 50(1):1-4. PubMed ID: 9662732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bitemporal electroconvulsive therapy for depression in a Parkinson disease patient with a deep-brain stimulator.
    Bailine S; Kremen N; Kohen I; Linder H; Schwartz GJ; Mogilner AY; Pourfar M
    J ECT; 2008 Jun; 24(2):171-2. PubMed ID: 18580566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of neurotrophins and serotonergic function in mice with genetically reduced glucocorticoid receptor expression.
    Schulte-Herbrüggen O; Hellweg R; Chourbaji S; Ridder S; Brandwein C; Gass P; Hörtnagl H
    Exp Neurol; 2007 Mar; 204(1):307-16. PubMed ID: 17208231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.